Achieving Launch Excellence in oncology is increasingly challenging. Innovators face overwhelming complexity, opportunity fragmentation and a widening 'innovation readiness' gap, as healthcare systems cannot keep up with the pace of oncology innovation to effectively adopt new therapies.
This white paper explores the key factors for helping pharmaceutical companies navigate these harsh realities to achieve commercial success in oncology today and in future.
Providing insights into oncology biomarker testing from laboratory directors' perspective
Re-imagine growth with health system outcomes in mind
How to succeed in an increasingly unforgiving oncology marketplace
IQVIA experts share their goals for propelling healthcare forward
Network Science supports effective Thought Leader targeting for the best launch and commercialization outcomes
Discover proven strategies and insights refined over more than 5,000 launches around the world.
Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
.svg){kind=icon}
